Patients w/ active intravascular clotting, predisposition to thrombosis; haematuria. Hemorrhage due to disseminated intravascular coagulation. Lysis of existing extravascular clots may be inhibited. Renal impairment. Patients after a subarachnoid hemorrhage. Avoid rapid IV use. Perform regular eye exam & liver function tests for long-term use.